MAPT and frontotemporal dementia: [6], we therefore analyzed existing data we held on 704 patients with FTD and 452 healthy elderly controls using SPSS25 to test the hypothesis that ApoE genotype has a modifying effect on clinical phenotype in those with or expected to have tau pathology defined by a highly penetrant MAPT gene mutation or by neuropathological examination.